| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 14.04% | 0.00% | -2.86% | 0 | -56.96% | 2025-11-17 |
| 2 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 73.28% | 27.68% | -2.86% | 0 | -56.96% | 2025-07-11 |
| 3 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 34.98% | 0.00% | -2.86% | 0 | -56.96% | 2025-10-16 |
| 4 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 12.96% | 0.00% | -2.86% | 0 | -56.96% | 2025-10-23 |
| 5 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 9.27% | 0.00% | -2.86% | 0 | -56.96% | 2025-10-21 |
| 6 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 10.95% | 0.00% | -2.86% | 0 | -56.96% | 2025-11-04 |
| 7 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 23.01% | 0.00% | -2.86% | 0 | -56.96% | 2025-11-12 |
| 8 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 0.00% | 0.00% | -2.86% | 0 | -56.96% | 2025-12-17 |
| 9 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 15.60% | 0.00% | -2.86% | 0 | -56.96% | 2025-11-28 |
| 10 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 6.55% | 0.00% | -2.86% | 0 | -56.96% | 2025-12-08 |
| 11 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 2.64% | 0.00% | -2.86% | 0 | -56.96% | 2025-12-11 |
| 12 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 70.58% | 37.85% | -2.86% | 0 | -56.96% | 2025-07-08 |
| 13 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 48.59% | 13.38% | -2.86% | 0 | -56.96% | 2025-08-21 |
| 14 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 59.42% | 14.04% | -2.86% | 0 | -56.96% | 2025-08-18 |
| 15 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 48.59% | 15.14% | -2.86% | 0 | -56.96% | 2025-08-22 |
| 16 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 67.80% | 21.18% | -2.86% | 0 | -56.96% | 2025-07-02 |
| 17 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 40.50% | 0.00% | -2.86% | 0 | -56.96% | 2025-09-26 |
| 18 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 65.02% | 28.99% | -2.86% | 0 | -56.96% | 2025-07-15 |
| 19 | 李安飞 | 中信证券 | 医药生物 | 65.70% | -3.14% | 0.00% | -2.86% | 0 | -56.96% | 2025-12-12 |
| 20 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 11.37% | 0.00% | -2.86% | 0 | -56.96% | 2025-10-29 |